You are here
Articles
Posted on Thursday, January 1, 2009 - 8:10pm
This is a good resource for understanding the genetics of cancer cells etc.... link to site here
Posted on Thursday, January 1, 2009 - 7:47pm
Novartis Oncology, the manufacturer of Gleevec® & Tasigna® has established this Pregnancy Drug Exposure Registry to learn about pregnancy outcomes and the health of women who have taken Gleevec® and/or Tasigna®...
Posted on Friday, December 19, 2008 - 6:28pm
Rarer Cancer Forum have produced a booklet to advice consultants on appealing negative funding decisions from PCT's...
Posted on Friday, December 19, 2008 - 6:14pm
Capsule Summary CCO Independent Conference Coverage of the American Society of Hematology 2008 Annual Meeting*
Cytogenetic Response to Dasatinib Predictive for Progression-Free Survival in Imatinib-Resistant/Intolerant...
Posted on Friday, December 19, 2008 - 6:10pm
Summary Friday, December 19, 2008
Capsule SummaryCCO Independent Conference Coverage of the American Society of Hematology 2008 Annual Meeting*
*CCO is an independent medical education company that provides state-of-...
Posted on Friday, December 19, 2008 - 6:01pm
CCO Independent Conference Coverage of the American Society of Hematology 2008 Annual Meeting*
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare...
Posted on Friday, December 19, 2008 - 3:38pm
These letters are templates which you can use when writing to your PCT and MP when challenging negative funding decisions for alternatives to imatinib. f You should change the wording to suit your individual details and...
Posted on Friday, December 19, 2008 - 12:32pm
Scientists may be able to stop cancer spreading round the body
Scientists have discovered how cancer spreads round the body raising the possibility it could be stopped.
Posted on Friday, December 19, 2008 - 11:55am
New RCF report reveals striking postcode lottery in the chances of having an exceptional request for cancer treatment approved
Monday, August 11, 2008
Rarer Cancers Forum carried out an audit of the...
Posted on Friday, December 19, 2008 - 11:38am
YOUR PATIENT'S RIGHT TO TREATMENT,
written by Peter Telford
Your Patient's Right to Treatment: Applying for NHS Exceptional Funding for Treatment
This 32-page booklet was written by a barrister, Peter...
Posted on Friday, December 12, 2008 - 3:34pm
Novel Agents in CML Therapy:
Tyrosine Kinase Inhibitors and Beyond
Junia V. Melo (2) and Charles Chuah (1)
Posted on Friday, December 12, 2008 - 12:44pm
Press Release Source: Novartis Pharmaceuticals UK Ltd
Data Shows Longest Ever Survival for Patients With Life-Threatening Leukaemia Treated With Breakthrough Treatment
Monday December 8, 5:00 pm ET
- 86 Percent of...
Posted on Friday, December 12, 2008 - 12:32pm
Why Gleevec-type Drugs Control, But Do Not Eradicate, Leukemia
ScienceDaily (Dec. 11, 2008) — Oregon Health & Science University Knight Cancer Institute researchers are closer to understanding why certain chronic...
Posted on Friday, December 12, 2008 - 12:27pm
New Approach To Help Control Drug Resistance In Leukemia Identified
ScienceDaily (Mar. 25, 2008) — Oregon Health & Science University Cancer Institute researchers have found that an experimental drug known as SGX393...
Posted on Friday, December 12, 2008 - 12:20pm
Combination Of Two Novel Anti-cancer Agents May Help Fight CML Resistant To Current Therapy
ScienceDaily (June 1, 2008) — Virginia Commonwealth University Massey Cancer Center researchers have identified that a...
- ‹ previous
- 29 of 33
- next ›